Long-Term Efficacy and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: Real-World Clinical Experience

Homozygous familial hypercholesterolemia (HoFH) is a rare, genetic condition characterized by markedly elevated plasma low-density lipoprotein cholesterol (LDL-C) concentrations from birth and increased risk of premature atherosclerotic cardiovascular disease. Evinacumab is an inhibitor of angiopoie...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefanutti, Claudia, Chan, Dick C., Di Giacomo, Serafina, Morozzi, Claudia, Watts, Gerald F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698659/
https://www.ncbi.nlm.nih.gov/pubmed/36422519
http://dx.doi.org/10.3390/ph15111389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698659/
https://www.ncbi.nlm.nih.gov/pubmed/36422519
http://dx.doi.org/10.3390/ph15111389

Ejemplares similares